Evidence map›Paper›PMID 36079030›Full record

ArticleJournal of clinical medicine2022

Retinal Vascular Occlusion after COVID-19 Vaccination: More Coincidence than Causal Relationship? Data from a Retrospective Multicentre Study.

Nicolas Feltgen, Thomas Ach, Focke Ziemssen, Carolin Sophie Quante, Oliver Gross, Alaa Din Abdin, Sabine Aisenbrey, Martin C Bartram, Marcus Blum, Claudia Brockmann and 32 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Big data are needed for analysis of the association of retinal vascular occlusion and COVID-19.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Nicolas FeltgenClinic of Ophthalmology, University Medical Centre Goettingen, 37075 Goettingen, Germany.ORCID 0000-0002-6857-3003
Thomas AchDepartment of Ophthalmology, University Hospital Bonn, 53127 Bonn, Germany.
Focke ZiemssenDepartment of Ophthalmology, University Leipzig, 04103 Leipzig, Germany.ORCID 0000-0002-3873-0581
Carolin Sophie QuanteMedical School, University Medical Centre Goettingen, 37075 Goettingen, Germany.
Oliver GrossClinic of Nephrology and Rheumatology, University Medical Centre Goettingen, 37075 Goettingen, Germany.
Alaa Din AbdinDepartment of Ophthalmology, Saarland University Medical Centre UKS, 66421 Homburg/Saar, Germany.ORCID 0000-0001-8190-7277
Sabine AisenbreyDepartment of Ophthalmology, Vivantes Health Network Ltd., Neukoelln Hospital, 12351 Berlin, Germany.
Martin C BartramDepartment of Ophthalmology, Hannover Medical School, 30625 Hannover, Germany.
Marcus BlumDepartment of Ophthalmology, Helios Hospital Erfurt, 99089 Erfurt, Germany.
Claudia BrockmannDepartment of Ophthalmology, Universitätsmedizin Rostock, 18057 Rostock, Germany.
Stefan DithmarDepartment of Ophthalmology, Helios HSK Wiesbaden, 65191 Wiesbaden, Germany.
Wilko FriedrichsCharlottenklinik Ophthalmology, 70176 Stuttgart, Germany.
Rainer GuthoffDepartment of Ophthalmology, Faculty of Medicine, University Hospital Duesseldorf, 40225 Dusseldorf, Germany.
Lars-Olof HattenbachDepartment of Ophthalmology, Ludwigshafen Hospital, 67063 Ludwigshafen am Rhein, Germany.
Klaus R HerrlingerDepartment of Internal Medicine I, Asklepios Klinik Nord, 22417 Hamburg, Germany.
Susanne Kaskel-PaulDepartment of Ophthalmology, Maerkische Kliniken GmbH, 58515 Luedenscheid, Germany.
Ramin KhoramniaThe David J Apple Centre for Vision Research, Department of Ophthalmology, University Hospital Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0002-6237-7773
Julian E KlaasDepartment of Ophthalmology, University Hospital, LMU Munich, 80336 Munich, Germany.ORCID 0000-0003-3207-4517
Tim U KrohneDepartment of Ophthalmology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50937 Cologne, Germany.ORCID 0000-0003-2280-925X
Albrecht LommatzschDepartment of Ophthalmology, St. Franziskus-Hospital, 48145 Muenster, Germany.
Sabine LuekenDepartment of Ophthalmology, University of Luebeck, 23538 Luebeck, Germany.
Mathias MaierOphthalmology Department, Hospital Rechts der Isar, Technical University of Munich (TUM), 81675 Munich, Germany.
Lina NassriDepartment of Ophthalmology, University Hospital RWTH Aachen, 52074 Aachen, Germany.
Thien A Nguyen-DangPraxis Prof. Laube, 40212 Duesseldorf, Germany.
Viola RadeckDepartment of Ophthalmology, University Hospital of Regensburg, 93049 Regensburg, Germany.ORCID 0000-0001-9312-4085
Saskia RauDepartment of Ophthalmology, Charité-University Medicine Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin and Berlin Institute of Health, 13353 Berlin, Germany.
Johann RoiderClinic of Ophthalmology, University Hospital Schleswig-Holstein, Kiel Campus, 24105 Kiel, Germany.
Dirk SandnerDepartment of Ophthalmology, University Hospital Carl Gustav Carus, Technical University of Dresden, 01307 Dresden, Germany.
Laura SchmalenbergerMunicipal Clinic Braunschweig, 38126 Braunschweig, Germany.
Irene SchmidtmannInstitute of Medical Biostatistics, Epidemiology and Informatics, University Medical Centre of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.ORCID 0000-0001-8743-6752
Florian SchubertDepartment of Ophthalmology, Phillips University of Marburg, 35043 Marburg, Germany.
Helena SiegelEye Centre, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Martin S SpitzerDepartment of Ophthalmology, University Medical Centre Hamburg-Eppendorf, 20251 Hamburg, Germany.
Andreas StahlDepartment of Ophthalmology, University Medical Centre Greifswald, 17475 Greifswald, Germany.ORCID 0000-0002-8013-7597
Julia V StinglDepartment of Ophthalmology, Medical Centre of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.ORCID 0000-0002-9684-7753
Felix TreumerDepartment of Ophthalmology, Klinikum Kassel, 34125 Kassel, Germany.
Arne ViestenzDepartment of Ophthalmology, Martin-Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Joachim WachtlinDepartment of Ophthalmology, Sankt-Gertrauden Krankenhaus, 10713 Berlin, Germany.
Armin WolfDepartment of Ophthalmology, Ulm University Medical Centre, 89075 Ulm, Germany.
Julian ZimmermannDepartment of Ophthalmology, University of Muenster Medical Centre, 48149 Muenster, Germany.ORCID 0000-0002-0007-147X
Marc SchargusAsklepios Augenklinik Nord, 22417 Hamburg, Germany.ORCID 0000-0003-4445-4103
Alexander K SchusterDepartment of Ophthalmology, Medical Centre of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo investigate whether vaccination against SARS-CoV-2 is associated with the onset of retinal vascular occlusive disease (RVOD).

methodsIn this multicentre study, data from patients with central and branch retinal vein occlusion (CRVO and BRVO), central and branch retinal artery occlusion (CRAO and BRAO), and anterior ischaemic optic neuropathy (AION) were retrospectively collected during a 2-month index period (1 June-31 July 2021) according to a defined protocol. The relation to any previous vaccination was documented for the consecutive case series. Numbers of RVOD and COVID-19 vaccination were investigated in a case-by-case analysis. A case-control study using age- and sex-matched controls from the general population (study participants from the Gutenberg Health Study) and an adjusted conditional logistic regression analysis was conducted.

resultsFour hundred and twenty-one subjects presenting during the index period (61 days) were enrolled: one hundred and twenty-one patients with CRVO, seventy-five with BRVO, fifty-six with CRAO, sixty-five with BRAO, and one hundred and four with AION. Three hundred and thirty-two (78.9%) patients had been vaccinated before the onset of RVOD. The vaccines given were BNT162b2/BioNTech/Pfizer (

conclusionsTo date, there has been no evidence of any association between SARS-CoV-2 vaccination and a higher RVOD risk.

Indexed as

anterior ischaemic optic neuropathyCOVID-19infectionretinal artery occlusionretinal vein occlusionSARS-CoV-2vaccination

Identifiers

PMID36079030
PMCPMC9457026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.